Eos BioInnovation
VC Fund
Cambridge, United States
Eos BioInnovation is an investment firm launching and building start-ups in the area of regenerative medicine and encompasses therapies.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 40%
Last updated:
For AI agents: llms.txt
Industries Eos BioInnovation invests in
Stages Eos BioInnovation invests in
Countries Eos BioInnovation invests in
Investment Focus
Industry
- Biotechnology 3 (60%)
- Medical 1 (20%)
- Biopharma 1 (20%)
- Health Care 1 (20%)
- Life Science 1 (20%)
Stage
- Seed 3 (60%)
- Series A 1 (20%)
Country
- Canada 1 (20%)
- Switzerland 1 (20%)
- United States 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Autoimmunity BioSolutions
|
Autoimmunity BioSolutions is working on a next-generation immuno-corrective therapy that restores normal immune function in a genetically defined subgroup of autoimmune patients, where the autoimmune pathology is driven by an SNP. | $1M / Seed / May 06, 2026 | |
TECregen
|
TECregen is a biotechnology company that develops thymus-rejuvenating biologics to restore immune function and T-cell responses. | $12.5M / Seed / Jan 08, 2026 | |
|
Autoimmunity BioSolutions
|
Autoimmunity BioSolutions is working on a next-generation immuno-corrective therapy that restores normal immune function in a genetically defined subgroup of autoimmune patients, where the autoimmune pathology is driven by an SNP. | $2M / Seed / Nov 21, 2024 | |
Axonis Therapeutics
|
Axonis translates breakthrough regeneration research to groundbreaking paralysis therapy, to transform the lives of spinal cord injury patients. | $115M / Series A / Oct 30, 2024 | |
HDAX Therapeutics
|
HDAX Therapeutics is pioneering next-gen precision therapeutics for cardiovascular and neurological diseases by targeting their root causes to enhance patient outcomes. | $3.2M / Seed / Sep 05, 2024 |
Co-Investors
Alexandria Venture Investments
2 deals together
Boehringer Ingelheim Venture Fund
2 deals together
FACIT
2 deals together
Independent Capital Management, Inc.
2 deals together
Anges Quebec
1 deal together
BoxOne Ventures
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Eos BioInnovation invest in?
Eos BioInnovation invests primarily in Biotechnology, Medical and Biopharma startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Eos BioInnovation last invest?
The most recent investment recorded for Eos BioInnovation closed in May 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
